- Biocon Q1 net profit drops 51.2% to Rs81.3 crore 28 July 2017
- Biocon gets EU nod for generic cholesterol drug 16 February 2016
- India poor in science, technology investment: Biocon chief 10 February 2016
- Biocon Q4 net profit surges 78% to Rs202 cr 30 April 2015
- Biocon plans to set up manufacturing unit in Visakapatanam 15 December 2014
- Biocon to buy back GE Capital stake in Syngene for Rs215 crore 09 September 2014
- Biotech firm Biocon ties up with Baxter for new research centre 06 February 2014
- Biocon to launch breast cancer drug 'CANMAb' next month 18 January 2014
- Mylan ropes in Biocon's marketing head Rakesh Bamzai 03 January 2014
- Biocon, Mylan get approval for biosimilar cancer drug Trastuzumab 28 November 2013
- Biocon reports 13% rise in quarterly net profit at Rs102 crore 26 October 2013
- Biocon receives marketing authorisation for psoriasis drug 08 January 2013
- Biocon in pact with Bristol-Myers Squibb for oral insulin 16 November 2012
- Biocon posts good Q2 result; shares up 31 October 2012
- Biocon among top 20 employers in sector: survey 25 September 2012
- Biocon plans merger with biopharma subsidiary 18 July 2012
- Biocon posts Rs86 crore net profit for quarter ended September 22 October 2011
- Biocon to set biopharmaceutical plant, R&D centre in Malaysia 12 September 2011
- Biocon to divest stake in Germany's AxiCorp 28 April 2011
- Biocon to invest $161 million in Malaysian biotech firm 28 October 2010
- Biocon second-quarter bottomline up 20 per cent Y-O-Y 22 October 2010
- Pfizer, Biocon enter into deal for biosimilar insulin 19 October 2010
- Havana's CIM S A to collaborate in immunology research with Biocon 27 September 2010
- Biocon net profit up 33 per cent 24 July 2010
- Biocon, HCG hospitals team up to fight cervical cancer 10 December 2009
- Hunduja's Gulf Oil sells IDL Specialty Chemicals to Biocon 01 October 2009
- Biocon in hybrid drug development pact with Amylin 11 September 2009
- Biocon Q1 net profit rises four-fold to Rs57 crore 23 July 2009
- Biocon, Mylan tie up for generic biologic drugs 29 June 2009
- Biocon's Q4 profit plummets by 62 per cent 28 April 2009
- Biocon eyes more acquisitions overseas 27 February 2008
- Biocon plans Rs 100 crore annual research spend 31 October 2007
- Biocon enters into JV with Neopharma of UAE 30 July 2007
- Biocon signs MoU with Australia's Deakin University 08 June 2007
- Biocon eyes more research outsourcing deals 22 March 2007
- Biocon to invest Rs 1,000 crore in Vizag SEZ 17 February 2007
- Biocon grants marketing license for cancer drug in Pakistan 18 January 2007
- Biocon in joint venture with Abu Dhabi-based Neopharma 06 January 2007
- Biocon launches cancer anti-body drug BioMab-EGFR 18 September 2006
- Biocon Biopharmaceuticals' new biologics facility 17 April 2006
- The Biocon story 07 May 2004
- Biocon issue oversubscribed 12 March 2004
- Biocon issue will sail through : Kiran Mazumdar 03 March 2004
- Biocon IPO opens on March 11 28 February 2004
